10x Genomics Inc (TXG) Implied Volatility Current

Tracking TXG implied volatility helps you identify when options premiums on 10x Genomics Inc are historically cheap or expensive, and where the best trades are hiding. 10x Genomics Inc implied volatility reflects the market's expectation of future price movement: when TXG IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor 10x Genomics Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For TXG, tracking metrics like TXG IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on TXG signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment.

The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where TXG implied volatility sits today versus where it has been. Our scanner ranks 10x Genomics Inc implied volatility against its historical range, surfaces extremes in TXG IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether 10x Genomics Inc IV is rich or cheap — measure it, then act on it.